EA
BEAT

Emerald Advisers’s BioTelemetry, Inc. BEAT Stock Holding History

Emerald Advisers’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,094
Closed -$187K – 368
2020
Q3 		$187K Hold
4,094
– – 0.01% 227
2020
Q2 		$185K Buy
+4,094
New +$183K 0.01% 224
2020
Q1 		– Sell
-13,082
Closed -$606K – 361
2019
Q4 		$606K Hold
13,082
– – 0.03% 175
2019
Q3 		$533K Hold
13,082
– – 0.02% 179
2019
Q2 		$630K Sell
13,082
-2,530
-16% -$133K 0.03% 177
2019
Q1 		$978K Hold
15,612
– – 0.04% 169
2018
Q4 		$932K Sell
15,612
-5,565
-26% -$334K 0.05% 155
2018
Q3 		$1.36M Hold
21,177
– – 0.05% 155
2018
Q2 		$953K Sell
21,177
-1,327
-6% -$52.9K 0.04% 186
2018
Q1 		$699K Hold
22,504
– – 0.03% 203
2017
Q4 		$673K Sell
22,504
-107
-0.5% -$3.1K 0.03% 195
2017
Q3 		$746K Hold
22,611
– – 0.03% 187
2017
Q2 		$756K Sell
22,611
-1,660
-7% -$49.5K 0.03% 180
2017
Q1 		$703K Buy
24,271
+1,237
+5% +$30.6K 0.03% 195
2016
Q4 		$515K Sell
23,034
-222,027
-91% -$4.34M 0.02% 201
2016
Q3 		$4.55M Sell
245,061
-151,435
-38% -$2.86M 0.2% 141
2016
Q2 		$6.46M Sell
396,496
-127,200
-24% -$1.87M 0.31% 109
2016
Q1 		$6.12M Sell
523,696
-77,234
-13% -$863K 0.3% 110
2015
Q4 		$7.02M Buy
600,930
+1,137
+0.2% +$14.4K 0.33% 103
2015
Q3 		$7.34M Sell
599,793
-24,044
-4% -$307K 0.38% 92
2015
Q2 		$5.88M Buy
623,837
+89,189
+17% +$825K 0.28% 113
2015
Q1 		$4.65M Sell
534,648
-8,840
-2% -$89.3K 0.23% 134
2014
Q4 		$5.45M Sell
543,488
-16,241
-3% -$139K 0.29% 112
2014
Q3 		$3.76M Hold
559,729
– – 0.22% 143
2014
Q2 		$4.01M Buy
559,729
+1,824
+0.3% +$14.5K 0.23% 144
2014
Q1 		$5.63M Buy
557,905
+34,975
+7% +$322K 0.32% 113
2013
Q4 		$4.15M Buy
522,930
+268,430
+105% +$2.51M 0.22% 140
2013
Q3 		$2.52M Buy
+254,500
New +$2M 0.14% 172

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Emerald Advisers's BEAT Position: Q4 2020 in Review

Emerald Advisers sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 4,094 shares — an estimated $187K sold.

Emerald Advisers first reported a position in BEAT in Q3 2013 and held it in 28 quarters. The position peaked at $7.34M in Q3 2015. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Emerald Advisers reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Emerald Advisers sold 4,094 BioTelemetry, Inc. shares in Q4 2020, an estimated $187K.
  • Emerald Advisers first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 28 quarters.
  • Emerald Advisers's BioTelemetry, Inc. position peaked at $7.34M in Q3 2015.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.